PCI Pharma Services has announced its intent to acquire Australia-based Pharmaceutical Packaging Professionals (PPP) involved in services associated with clinical trial manufacturing, packaging, storage and distribution.
The acquisition is expected to establish PCI’s footprint in Australia and aid in the firm’s growth and expansion in the Asia Pacific region through PPP’s existing market presence in countries such as China, Korea, Vietnam, Sri Lanka, Taiwan, Malaysia, Thailand and New Zealand.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Through the deal, PCI also plans to leverage PPP’s Phase I offering to support its customers from initial clinical development phases until commercial launch.
PPP’s clinical trial supply services include manufacturing of early clinical phase sterile and non-sterile investigational products, their packaging and labelling, along with logistics such as storage, distribution and global investigational sites.
These services are expected to complement PCI’s portfolio of clinical and commercial scale services, including drug manufacturing, packaging and labelling of trial medicines, commercial contract packaging and logistical services to sites.
Furthermore, PPP’s expertise on supporting various temperature environments will bolster PCI’s current storage, packaging and shipping capabilities for Cold Chain products.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataPCI Pharma Services president and CEO Bill Mitchell said: “Our customers continue to seek new markets both for execution of their clinical studies, as well as partners that can support them through the supply chain.
“This opportunity is part of our next logical phase of geographic expansion and enables us to support our customers in their long-term global growth strategies.
“Additionally, PPP’s highly experienced management team has a strong track record in the clinical trials marketplace and we are excited to welcome them to PCI.”
The new deal will follow PCI’s previous purchase of Ireland-based pharmaceutical and healthcare contract packaging services firm Millmount Healthcare that added four facilities to its supply network.
